Kayne Anderson Rudnick Investment Management
HCAT icon

Kayne Anderson Rudnick Investment Management’s Health Catalyst HCAT Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32
Closed -$1K – 634
2022
Q1 		$1K Buy
+32
New +$908 ﹤0.01% 631

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's HCAT Position: Q2 2022 in Review

Kayne Anderson Rudnick Investment Management sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 32 shares — an estimated $1K sold.

Kayne Anderson Rudnick Investment Management first reported a position in HCAT in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 180 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

  • Kayne Anderson Rudnick Investment Management reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 32 Health Catalyst shares in Q2 2022, an estimated $1K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Health Catalyst in Q1 2022 and held it in 1 quarter.
  • Kayne Anderson Rudnick Investment Management's Health Catalyst position peaked at $1K in Q1 2022.
  • 180 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.